Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

These shares are ending the week with a bang. But why? Let's find out.

| More on:
A smiling businessman in the city looks at his phone and punches the air in celebration of good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to end the week on a positive note. In afternoon trade, the benchmark index is up 0.4% to 8,232.7 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Cettire Ltd (ASX: CTT)

The Cettire share price is up 3.5% to $1.62. This is despite there being no news out of the online luxury products retailer. However, with its shares down over 40% since this time last year and 67% from their 52-week high, it seems that some investors believe that a buying opportunity has been created.

Gold Road Resources Ltd (ASX: GOR)

The Gold Road share price is up almost 3% to $2.12. This follows a decent night of trade for the gold price on Wall Street. According to CNBC, the gold futures price was up over 1% to US$2,668.8 an ounce during overnight trade on safe haven demand. This meant that the precious metal climbed to a two-week high. It isn't just Gold Road Resources that is rising today. The S&P/ASX All Ordinaries Gold index is up 2.5% at the time of writing.

Imugene Ltd (ASX: IMU)

The Imugene share price is up 2.5% to 4 cents. This morning, this immuno-oncology company released an update on its phase 1b clinical trial of its allogeneic CAR T-cell therapy azer-cel at the Royal Prince Alfred Hospital (RPAH) in Sydney. It is focused on patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), which is one of the most challenging and aggressive forms of non-Hodgkin's lymphoma. According to the release, the first Australian patient has been dosed in the Phase 1b clinical trial at the RPAH. Imugene CEO, Leslie Chong, said: "Achieving first patient dosed for azer-cel in Australia represents a significant milestone for Imugene and for Australian patients battling this devastating disease."

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 8% to $8.53. A number of ASX 200 uranium stocks are racing higher on Friday after industry giant Cameco announced the suspension of production at its joint venture with Kazatomprom. Cameco stated: "We are disappointed and surprised by this unexpected suspension and we will be seeking further clarification on how this transpired, as well as the potential 2025 and 2026 production and financial impacts (including on future dividends), and what Cameco can do to help Kazatomprom and JV Inkai restart mining operations."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BlueScope, DroneShield, Monadelphous, and SGH shares are racing higher today

These shares are outperforming on Tuesday. But why?

Read more »

Man looking at digital holograms of graphs, charts, and data.
Share Gainers

Top 5 ASX 200 tech shares for growth in 2025

It was a rollercoaster year for ASX 200 tech shares, with fears of an AI bubble sending them into a bear…

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a lukewarm start to the week today.

Read more »

A young woman raises her arm in celebration against a backdrop of brightly coloured fireworks in the sky.
Share Gainers

Buying ASX uranium shares like Paladin Energy? Here's why they're starting 2026 with a bang!

Investors are piling into ASX uranium stocks in these early days of 2026. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Civmec, Fenix, Paladin Energy, and Vulcan Steel shares are pushing higher today

These shares are starting the week on a positive note.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, Elsight, Judo, and Nickel Industries shares are pushing higher today

These shares are starting the year in a positive fashion. But why?

Read more »